WHO ICTRP trial

To study the efficacy of homoeopathy in management of rheumatoid arthritis

CTRI/2026/01/101901 · Clinical Trials Registry India (CTRI) · Not Recruiting

Key facts

Trial ID CTRI/2026/01/101901
Public title To study the efficacy of homoeopathy in management of rheumatoid arthritis
Scientific title A comparative study to assess the effectiveness of individualised homoeopathic medicines with standard line of treatment in the improvement of disease activity score in management of rheumatoid arthritis: a randomized controlled trial - NIL
Primary sponsor Dr Preeti Lamba
Registry Clinical Trials Registry India (CTRI)
Recruitment status Not Recruiting
Study type Interventional
Phase Phase 3
Countries India
Conditions Health Condition 1: M057- Rheumatoid arthritis with rheumatoid factor without organ or systems involvement
Interventions Intervention1: Individualised Homoeopathic Medicines: Individualised Homoeopathic Medicines will be administered to 100 Patients (Group A) of Rheumatoid Arthritis as intervention and effect will be compared with the comparator which is…
Registration date Jan 23, 2026
Target size 200
Secondary IDs NIL
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations